TokenPost·

Bristol Myers Squibb Says KarXT Improved Alzheimer’s Psychosis Scores

Your call?

The two Phase 3 trials found gains in hallucination and delusion scores, and the xanomeline and trospium chloride treatment was well tolerated.

Share

More news